Search results for " biomarker"

showing 8 items of 478 documents

Valorization of Side Stream Products from Sea Cage Fattened Bluefin Tuna (Thunnus thynnus): Production and In Vitro Bioactivity Evaluation of Enriche…

2022

The valorization of side streams from fishery and aquaculture value-chains is a valuable solution to address one of the challenges of the circular economy: turning wastes into profit. Side streams produced after filleting of sea cage fattened bluefin tuna (Thunnus thynnus) were analyzed for proximate composition and fatty acid profile to evaluate the possibility of producing tuna oil (TO) as a valuable source of ω-3 polyunsaturated fatty acids (PUFA) and testing its bioactivity in vitro. Ethyl esters of total fatty acids (TFA), obtained from TO, were pre-enriched by urea complexation (PUFA-Ue) and then enriched by short path distillation (SPD) up to almost 85% of the PUFA fraction (PU…

side streamsfood and beveragesbiomarkersPharmaceutical Scienceω-3 fatty acidseye diseasesadipogenesisSAF-1 cell lineSettore AGR/20 - Zoocoltureside streams; ω-3 fatty acids; tuna fish oils; SAF-1 cell line; biomarkers; lipid metabolism; adipogenesislipid metabolismDrug Discoverylipids (amino acids peptides and proteins)Settore BIO/06 - Anatomia Comparata E Citologiahuman activitiesPharmacology Toxicology and Pharmaceutics (miscellaneous)tuna fish oilsMarine Drugs
researchProduct

miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty Syndrome

2022

Frailty is an aging-related pathology, defined as a state of increased vulnerability to stressors, leading to a limited capacity to meet homeostatic demands. Extracellular microRNAs (miRNAs) were proposed as potential biomarkers of various disease conditions, including age-related pathologies. The primary objective of this study was to identify blood miRNAs that could serve as potential biomarkers and candidate mechanisms of frailty. Using the Fried index, we enrolled 22 robust and 19 frail subjects. Blood and urine samples were analysed for several biochemical parameters. We observed that sTNF-R was robustly upregulated in the frail group, indicating the presence of an inflammatory state. …

smRNA-seqmicroRNAFrailtymiR-142-5pBiomarkers; Frailty; MicroRNA; MiR-101-3p; MiR-142-5p; MiRNome; RNA-seq; SmRNA-seqbiomarkersmiRNomeReal-Time Polymerase Chain ReactionmicroRNA; frailty; smRNA-seq; miRNome; biomarkers; RNA-seq; miR-101-3p; miR-142-5pMicroRNAsGeneticsbiomarkerHumansRNA-seq; biomarkers; frailty; miR-101-3p; miR-142-5p; miRNome; microRNA; smRNA-seq; Biomarkers; Humans; Real-Time Polymerase Chain Reaction; Frailty; MicroRNAsRNA-seqmiR-101-3pGenetics (clinical)Genes; Volume 13; Issue 2; Pages: 231
researchProduct

Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer

2022

Simple Summary Non-small cell lung cancer (NSCLC) is the second most commonly diagnosed cancer and the leading cause of cancer-related death worldwide. Clinical decision-making depends on the histological classification; however, tissue biopsy is frequently not technically feasible due to tumor location or limited tissue samples. Therefore, we propose to find clinical, molecular and histological biomarkers using a minimally invasive approach based on the analysis of the cargo of the blood extracellular vesicles. Exosomes are membranous vesicles present in several biological fluids, which carry biological information to distant tissues, regulating several tumor processes. This study aims to …

squamous cell carcinomaCancer ResearchtumorspheresMICRORNASBIOMARKERSCANCER/TESTIS ANTIGENexosomesNSCLCnon-small cell lung cancer; liquid biopsy; exosomes; extracellular vesicles; cell cultures; adenocarcinoma; squamous cell carcinoma; biomarker; tumorspheresMECHANISMSRNASMICROARRAYIMMUNOTHERAPYCàncernon-small cell lung cancerScience & Technologyadenocarcinomaliquid biopsycell culturesSTATISTICSOncologyPulmonsbiomarkerextracellular vesiclesLife Sciences & Biomedicine
researchProduct

The matrix metalloproteinase and insulin-like growth factor system in oral cancer : a prospective clinical study

2017

Aim The absence of reliable single serum biomarkers for oral premalignant lesion (OPL) and oral squamous cell carcinoma (OSCC) limits early diagnosis, monitoring of advanced disease, and prediction of prognosis. Methods In this prospective study, serum levels of matrix metalloproteinase (MMP)-2, MMP-3, MMP-13, insulin-like growth factor (IGF)-1, and IGF-binding protein (IGFBP)-3 were measured in 81 untreated OSCC patients, 49 healthy subjects, and 75 individuals with OPLs, and correlated with clinicopathological parameters. Results Serum levels of MMP-3 were significantly higher in OSCC patients compared to healthy subjects (p=0.004). Mean IGF-1 and IGFBP-3 levels in OSCC patients were sign…

stomatognathic diseasesMMP610 Medical sciencesserum biomarker610 MedizinOSCCoral premalignant lesionprognosisoral cancerIGFOriginal Research
researchProduct

Inflammatory response elements, glycan, and proteome profiles as salivary biomarkers for the early diagnosis of OSCC

2021

El cáncer oral, sobre todo el, carcinoma oral de células escamosas (COCE), es la neoplasia maligna más común en la cavidad oral que se caracteriza por un mal pronóstico y una baja tasa de supervivencia, cuando se diagnostica en estadios avanzados. Puede ser tratado de forma efectiva si se detecta en estadios iniciales, mejorando el pronóstico. Por tanto, tras la prevención, el diagnóstico precoz se ha convertido en el principal objetivo en el manejo del cáncer oral, dado su impacto positivo en la supervivencia y calidad de vida de estos pacientes. A menudo, los escasos síntomas iniciales pasan desapercibidos y la enfermedad se descubre en fases avanzadas, por lo que se requiere mejorar el d…

stomatognathic diseasessaliva testingtranslational researchUNESCO::CIENCIAS MÉDICASnon-invasive diagnostic biomarkersoral cancer:CIENCIAS MÉDICAS [UNESCO]oral leukoplakia
researchProduct

The matrix metalloproteinase and insulin-like growth factor system in oral cancer – a prospective clinical study

2017

Eik Schiegnitz,1 Peer W Kämmerer,2 Holger Schön,1 Christoph Gülle,1 Manfred Berres,3,4 Keyvan Sagheb,1 Bilal Al-Nawas5 1Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Center, Johannes Gutenberg University of Mainz, Mainz, 2Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Centre Rostock, Rostock, 3Department of Mathematics and Technology, University of Applied Sciences Koblenz, Remagen, 4Institute of Medical Biometry, Epidemiology and Informatics, Johannes Gutenberg University of Mainz, Mainz, 5Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Centre, Martin-Luther University Ha…

stomatognathic diseasesserum biomarkerOSCCoral premalignant lesionprognosisoral cancerlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282OncoTargets and Therapy
researchProduct

Extracellular Vesicles as Shuttles of Tumor Biomarkers and Anti-Tumor Drugs

2014

Extracellular vesicles (EV) include vesicles released by either normal or tumor cells. EV may exceed the nanometric scale (microvesicles), or to be within the nanoscale, also called exosomes. Thus, it appears that only exosomes and larger vesicles may have the size for potential applications in nanomedicine, in either disease diagnosis or therapy. This is of particular interest for research in cancer, also because the vast majority of existing data on EV are coming from pre-clinical and clinical oncology. We know that the microenvironmental features of cancer may favor cell-to-cell paracrine communication through EV, but EV have been purified, characterized, and quantified from plasma of tu…

tumorsCancer Researchbusiness.industryVesicleParacrine CommunicationbiomarkersCancerexosomeslcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensBioinformaticsmedicine.diseaselcsh:RC254-282Extracellular vesiclesMicrovesiclesAnti-Tumor DrugsteranosticsTumor BiomarkersOncologyPerspective ArticleCancer researchmedicineNanomedicineextracellular vesiclesbusinessFrontiers in Oncology
researchProduct

Oxidative stress biomarkers in the copepod Limnocalanus macrurus from the northern Baltic Sea : effects of hydrographic factors and chemical contamin…

2015

zooplanktonBaltic SeaympäristötekijätLimnocalanus macruruseläinplanktonAquatic ScienceZooplanktonoksidatiivinen stressibiologiset menetelmätEcology Evolution Behavior and SystematicsEcologybiologyplanktonoxidative stress biomarkersLimnocalanus macrurusstressiContaminationbiology.organism_classificationFisheryOceanographyBaltic seamarkkeritItämeriEnvironmental scienceta1181hankajalkaisetHydrographyCopepodMarine Ecology Progress Series
researchProduct